Loading organizations...

§ Private Profile · 1650 Ramblewood Dr STE 200, East Lansing, MI 48823, USA
Salvo Health provides app-based specialty care for chronic gut conditions.
Salvo Health operates as a virtual health clinic platform focused on delivering integrated care for individuals living with chronic gastrointestinal and metabolic liver conditions. The company combines cross-functional care teams with tech-enabled tooling, utilizing a comprehensive approach it terms "Whole Self Science™." This platform assists providers in transitioning from episodic care to continuous, holistic patient management, enhancing outcomes through a digital-first model that integrates various specialty services.
Co-founded by Jeff Glueck, Salvo Health was established with the insight that specialty medicine, particularly for chronic conditions like those affecting the gut, required a new approach. The founders recognized the need to move beyond fragmented care to a more integrated, patient-centric model. Their vision was to leverage technology to provide accessible, advanced specialty healthcare that addresses the complex needs of patients holistically.
The company primarily serves individuals with chronic GI issues, connecting them with interdisciplinary care teams that may include registered dietitians and behavioral health specialists. Salvo Health's overarching mission is to radically expand access to high-quality specialty healthcare for anyone grappling with chronic conditions, beginning with gastrointestinal health. It aims to empower both patients and providers with tools and support for better long-term health management.
Salvo Health has raised $17.5M across 3 funding rounds.
Salvo Health has raised $17.5M in total across 3 funding rounds.
Salvo Health has raised $17.5M in total across 3 funding rounds.
Salvo Health's investors include City Light Capital, Matt Kinley, Threshold Ventures, Alumni Ventures, Contour Venture Partners, Felicis Ventures, Human Ventures, Eric Collins, Jennifer Fonstad, Diana Murakhovskaya, Katie Reiner, Rachel Parlier.
Salvo Health has raised $17.5M across 3 funding rounds. Most recently, it raised $8.5M Series A in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 26, 2026 | $8.5M Series A | City Light Capital, Matt Kinley, Threshold Ventures | Alumni Ventures, Contour Venture Partners, Felicis Ventures, Human Ventures, Eric Collins, Jennifer Fonstad, Diana Murakhovskaya, Katie Reiner | Announced |
| Feb 1, 2024 | $5M Seed | Human Ventures, Rachel Parlier | The Artemis Fund, Threshold Ventures, Torch Capital, Anmol Madan, RON Levin, Felicis Ventures | Announced |
| Aug 1, 2022 | $4M Seed | Threshold Ventures | Delta Emerald Ventures, Flexcap, Human Ventures, The Artemis Fund, Torch Capital, What IF Ventures, Alexander Saint Amand, Felicis Ventures | Announced |
Salvo Health is a digital-first healthcare company building an app-based specialty clinic that delivers continuous, interdisciplinary care for chronic gastrointestinal (GI) and metabolic liver conditions by combining physician-led teams, dietitians, behavioral health, remote monitoring and proprietary care protocols to increase access and outcomes for patients and providers[4][2].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: Salvo Health combines a clear clinical need, a multidisciplinary care design, device integrations and a provider‑friendly approach — positioning it to scale specialty chronic care if it can prove reproducible outcomes and durable reimbursement pathways[2][4][6].